PW Medtech Group Limited (HKG:1358)

Market Cap	1.66B +10.7%
Revenue (ttm)	916.40M +7.1%
Net Income	105.02M -37.4%
EPS	0.07 -36.1%
Shares Out	1.45B
PE Ratio	16.54
Forward PE	n/a
Dividend	0.06 (5.57%)
Ex-Dividend Date	Jul 2, 2026

Volume	242,000
Open	1.150
Previous Close	1.150
Day's Range	1.150 - 1.150
52-Week Range	0.970 - 1.630
Beta	0.69
Analysts	Hold
Price Target	2.33 (+102.61%)
Earnings Date	Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 1,440
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1358

Financial Performance

In 2025, PW Medtech Group's revenue was 823.51 million, an increase of 7.10% compared to the previous year's 768.90 million. Earnings were 94.37 million, a decrease of -37.41%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error